Neonatal Sepsis: Mortality and Morbidity in Neonatal Sepsis due to Multidrug-Resistant (MDR) Organisms: Part 1
Open Access
- 11 December 2019
- journal article
- review article
- Published by Springer Nature in Indian Journal of Pediatrics
- Vol. 87 (2) , 117-121
Abstract
The major causes of emergence of multidrug-resistant organisms (MDRO) in neonatal sepsis include empiric antibiotic prescriptions, unregulated use of over-the-counter drugs, high incidence of healthcare associated infections (HAI), lack of awareness about antibiotic stewardship program and under staffing of neonatal intensive care units. In general, mortality due to MDRO sepsis is significantly higher as compared to non MDRO sepsis. Reported morbidities include prolonged use of total parenteral nutrition, need for central venous catheter, invasive ventilation, increased duration of hospital stay and neurologic sequelae.Keywords
This publication has 30 references indexed in Scilit:
- Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales dataThe Lancet Infectious Diseases, 2014
- Risk Factors and Outcomes for Multidrug-Resistant Gram-Negative Bacteremia in the NICUPediatrics, 2014
- An evaluation of knowledge, attitude and practices about prescribing fixed dose combinations among resident doctorsPerspectives in Clinical Research, 2013
- Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000The Lancet, 2012
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClinical Microbiology and Infection, 2012
- Early Onset Neonatal Sepsis: The Burden of Group B Streptococcal and E. coli Disease ContinuesPediatrics, 2011
- Pathogens Associated With Sepsis in Newborns and Young Infants in Developing CountriesThe Pediatric Infectious Disease Journal, 2009
- Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial StewardshipClinical Infectious Diseases, 2007
- Attributable Costs and Length of Stay of an Extended-Spectrum Beta-Lactamase-ProducingKlebsiella pneumoniaeOutbreak in a Neonatal Intensive Care UnitInfection Control & Hospital Epidemiology, 2003
- Antimicrobial Growth Promoters Used in Animal Feed: Effects of Less Well Known Antibiotics on Gram-Positive BacteriaClinical Microbiology Reviews, 2003